- Home
- LSTA vs NXGL Comparison
LSTA vs NXGL Comparison
Compare LSTA & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- NXGL
- Stock Information
- Founded
- LSTA 1980
- NXGL 1997
- Country
- LSTA United States
- NXGL United States
- Employees
- LSTA N/A
- NXGL N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- NXGL Medical/Dental Instruments
- Sector
- LSTA Health Care
- NXGL Health Care
- Exchange
- LSTA Nasdaq
- NXGL Nasdaq
- Market Cap
- LSTA 22.3M
- NXGL 18.7M
- IPO Year
- LSTA N/A
- NXGL 2021
- Fundamental
- Price
- LSTA $2.21
- NXGL $2.51
- Analyst Decision
- LSTA Strong Buy
- NXGL
- Analyst Count
- LSTA 2
- NXGL 0
- Target Price
- LSTA $23.50
- NXGL N/A
- AVG Volume (30 Days)
- LSTA 23.3K
- NXGL 44.6K
- Earning Date
- LSTA 11-11-2025
- NXGL 11-12-2025
- Dividend Yield
- LSTA N/A
- NXGL N/A
- EPS Growth
- LSTA N/A
- NXGL N/A
- EPS
- LSTA N/A
- NXGL N/A
- Revenue
- LSTA $1,070,000.00
- NXGL $11,672,000.00
- Revenue This Year
- LSTA N/A
- NXGL $46.60
- Revenue Next Year
- LSTA N/A
- NXGL $47.96
- P/E Ratio
- LSTA N/A
- NXGL N/A
- Revenue Growth
- LSTA N/A
- NXGL 133.02
- 52 Week Low
- LSTA $1.87
- NXGL $2.10
- 52 Week High
- LSTA $4.20
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- LSTA 41.26
- NXGL 55.91
- Support Level
- LSTA $2.11
- NXGL $2.15
- Resistance Level
- LSTA $2.33
- NXGL $2.60
- Average True Range (ATR)
- LSTA 0.16
- NXGL 0.17
- MACD
- LSTA -0.00
- NXGL 0.02
- Stochastic Oscillator
- LSTA 25.93
- NXGL 80.72
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.